Cidara Therapeutics acquisition

1 articles
BenzingaBenzinga··Vandana Singh

Merck Reports Q1 Loss on Cidara Acquisition Charge, But Beats on Sales Growth

Merck posts Q1 loss on Cidara acquisition charge but beats revenue expectations with 5% sales growth, raises 2026 guidance.
MRKKeytrudaQ1 2026 earnings